As more companies explore oligonucleotides as part of their biopharma drug pipeline, the importance of developing an effective HPLC method is increasing. While
starting points for mobile phases, ion pairing agent, and example HPLC methods can be found in the literature, often these methods do not transfer across oligos.

Dorie Yontz of DuPont discusses its bioprocessing offering, the role of polymeric resins, and critical elements as they relate to manufacturing.

Emerging drug classes are giving rise to challenges in downstream processing, pushing the need for strategizing efficiencies.

DuPont Water Solutions and Xenon arc Launch directibility™

We are pleased to present the new look online home of DWS Advantage!